// App-Quantinova.ai

414 : Biochemical and cellular monitoring of the activity of the ecto-5-nucleotidase (CD73), a key cancer modulator using HTS-formatted bioluminescent technology

Researchers

Presenter

  • Said A. Goueli

Principal Investigators

  • Kevin hsiao

Medical Centers

  • Promega Corporation, Madison, WI.

Locations

  • United States

Companies

  • Promega Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • 5'-nucleotidase

  • Glycosylphosphatidylinositol

Drug/Treatment

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved